Adam Warren, Chief Executive Officer
With over 20 years of diverse pharmaceutical experience, Adam has developed an extensive history of defining and implementing advanced courses of action that optimize the operational complexities and cost efficiencies of global supply chain management.
In 2010, he founded Innovative Supply Solutions (ISS) to provide a full range of clinical drug supply management services to clients around the world. ISS has developed a powerful and accurate software platform capable of successfully refining supply chain management. It leverages real-time visibility to see, control and react to every clinical trial variable. This end to end approach seamlessly integrates each piece of the clinical supply chain at all phases and levels of complexity, allowing users to make rapid adjustments and maximize ROI.
Adam's extensive experience in supply chain management has given him an in-depth understanding of global regulatory compliance, as well as manufacturing, packaging and labeling, distribution and logistics. His career began at the R.W. Johnson Pharmaceutical Research Institute, followed by Ortho-McNeil, Astra Pharmaceuticals (Astra Merck) and AstraZeneca Pharmaceuticals. Prior to founding ISS, Adam spent five years at Johnson and Johnson Pharmaceutical Research and Development as Director of Customer Relationship Management in the Global Clinical Supplies Unit, where he led a seasoned team throughout the United States and Europe. While there, Adam put into practice a CRM model for enhanced operational productivity that generated cost efficiencies in the multi-million dollar range. He also served on the Senior Management team of the CSU and the U.S. ChemPharm Site Leadership Team.
Adam graduated from Penn State University with a bachelor's degree in Biology. He continued his studies at the Philadelphia College of Osteopathic Medicine where he earned a master's degree in Organizational Development and Leadership.
Adam Moskow, Board Member & Operations Advisor
Adam specializes in the areas of planning, funding, operations, recruiting key talent and coaching leaders in business. He oversees these areas and related matters in his instrumental role at Innovative Supply Solutions.
Adam has been working with ISS for the past four years providing key input to business strategy. Adam currently serves on the ISS Board and is acting COO.
Adam started his career at Goldman Sachs. He then joined Lapidary Journal as Vice President of Operations. In this role, Adam held business planning, recruiting, operations and P&L duties for a large group of media entities. He hired and directed a staff of 60 while reducing costs, driving revenue up $5 million and increasing profits by 600%. Adam then acquired half of S&D Marketing, a direct marketing customer acquisition firm. He was instrumental in advancing that business too, with it landing twice on the "Philadelphia 100" list of fast growing companies. From there, he helped run UnReal Marketing, an online advertising agency that also twice made the "Philadelphia 100" list. Since then, Adam and his team have helped companies they believe in to gain funding, recruit talent, improve operations and increase profitability.
Adam teaches venture planning classes at the Wharton Small Business Development Center and performs workshops for business groups on strategic planning and recruiting. He is also a highly sought after dynamic public speaker on various topics related to business success.
He graduated Magna Cum Laude from the Wharton School of Business at the University of Pennsylvania with a degree in Finance.
ADDITIONAL BOARD MEMBERS
Mike is a global leader in the field of global clinical trial supply, having worked with several of the largest pharmaceutical companies in the world. As the CEO of Myoderm, he's a specialist in sourcing, management, and labeling of commercial drugs and supplies.